Join the 'Renal Cell Carcinoma' group to help and get support from people like you.

Renal Cell Carcinoma Blog

Related terms: Adenocarcinoma of renal cells, Cancer, Hypernephroma, Cancer, Kidney, Cancer, Renal, Cancer, Renal Cell Carcinoma, Hypernephroma, Kidney Cancer, Renal Cancer

Agent Orange Linked to Kidney Cancer: Study

Posted 15 May 2011 by Drugs.com

SATURDAY, May 14 – There appears to be a link between Agent Orange and kidney cancer in U.S. veterans exposed to the herbicide in Vietnam, a new study suggests. Researchers at the Veterans Affairs Medical Center in Shreveport, La. examined the records of 297 patients diagnosed with kidney cancer between 1987 and 2009. Thirteen of the patients, aged 39 to 63 when they were diagnosed, said they had been exposed to Agent Orange. Documented exposure to the herbicide and pathology reports were available for 10 of the patients. The researchers reviewed these patients' age at diagnosis, tumor size, side of lesion, pathology and survival. Nine of the 10 patients had clear-cell cancers, which typically have worse outcomes than papillary tumors, which appeared in one patient. One patient had both clear-cell and papillary cancers. During the average follow-up of 54 months, four patients developed ... Read more

Related support groups: Renal Cell Carcinoma

Fewer Cancer Patients May Be Depressed Than Thought

Posted 20 Jan 2011 by Drugs.com

THURSDAY, Jan. 20 – The rate of depression among cancer patients may be lower than previously believed, a new study indicates. An international team of researchers analyzed 94 studies involving more than 14,000 patients and found that about one-sixth of cancer patients suffer depression and about one-third have a more widely defined mood disorder. Only modest rates of depression and anxiety occurred in cancer patients in the first five years after diagnosis, which suggests that depression is not inevitable in these patients, the researchers said. Only when it was combined with other mood disorders was depression common, occurring in 30 percent of hospitalized cancer patients. The study is published online Jan. 19 in The Lancet Oncology. Rates of depression and anxiety were not significantly different between patients receiving palliative care (care designed to ease pain and increase ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Renal Cell Carcinoma, Lung Cancer, Colorectal Cancer, Breast Cancer, Metastatic, Non-Small Cell Lung Cancer, Basal Cell Carcinoma, Brain Tumor, Pancreatic Cancer, Skin Cancer, Ovarian Cancer, Melanoma, Breast Cancer - Adjuvant, Osteosarcoma, Endometrial Cancer, Bladder Cancer, Cervical Cancer, Small Cell Lung Cancer

1 in 5 Cancer Survivors Suffers Chronic Pain, Study Finds

Posted 20 Jan 2011 by Drugs.com

WEDNESDAY, Jan. 19 – More than 40 percent of cancer survivors experience pain, and the risk is highest among black and female patients, finds a new study. Researchers at the University of Michigan Health System surveyed nearly 200 U.S. cancer survivors and found that 43 percent had experienced pain since their diagnosis, and 20 percent suffered chronic cancer-related pain at least two years later. Among white patients, the most significant source of pain was cancer surgery (53.8 percent), and among black patients the greatest source of pain was cancer treatment (46.2 percent), according to the report. In addition, the study found that compared to men, women had more pain, more pain flare-ups, more disability due to pain and were more depressed because of pain. The authors also noted that black patients were more likely to report greater severity of pain and more pain-related ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Renal Cell Carcinoma, Lung Cancer, Colorectal Cancer, Breast Cancer, Metastatic, Non-Small Cell Lung Cancer, Basal Cell Carcinoma, Brain Tumor, Pancreatic Cancer, Ovarian Cancer, Skin Cancer, Melanoma, Osteosarcoma, Breast Cancer - Adjuvant, Endometrial Cancer, Cervical Cancer, Bladder Cancer, Melanoma - Metastatic

Demand for Radiation Therapy Predicted to Exceed Supply

Posted 21 Oct 2010 by Drugs.com

THURSDAY, Oct. 21 – Over the next decade, the growth in demand for radiation therapy in the United States will be 10 times greater than the increase in new radiation oncologists, a difference that could affect cancer patients' access to treatment, according to a new study. Between 2010 and 2020, the number of patients requiring radiation therapy will increase 22 percent but the number of full-time radiation oncologists entering the workforce will increase just 2 percent, said researchers at the University of Texas M.D. Anderson Cancer Center in Houston and colleagues. They based their predictions on projections that this year 3,943 radiation oncologists will treat an estimated 470,000 patients in the United States. The large increase in demand for radiation therapy will be partly due to growing numbers of older adults and minorities, groups in which certain types of cancers are more ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Renal Cell Carcinoma, Lung Cancer, Colorectal Cancer, Breast Cancer, Metastatic, Non-Small Cell Lung Cancer, Basal Cell Carcinoma, Brain Tumor, Pancreatic Cancer, Ovarian Cancer, Skin Cancer, Melanoma, Osteosarcoma, Breast Cancer - Adjuvant, Endometrial Cancer, Cervical Cancer, Bladder Cancer, Melanoma - Metastatic

Cancer Patients' Secondary Symptoms Need Attention: Study

Posted 11 Oct 2010 by Drugs.com

MONDAY, Oct. 11 – Many cancer patients with pain or depression also experience physical symptoms, such as fatigue, dry mouth and nausea, that can cause disability, a new study shows. Doctors need to recognize and treat these symptoms in order to improve quality of life for cancer patients, said Dr. Kurt Kroenke, of the Richard Roudebush VA Medical Center, Indiana University, and Regenstrief Institute Inc. in Indianapolis, and colleagues. They analyzed data from 405 cancer patients who had either pain or depression and found that all the patients had at least one of 22 physical symptoms examined in the study. More than half of patients reported 15 of the 22 symptoms. The most common symptoms were fatigue (97.5 percent), difficulty sleeping (about 79 percent), pain in limbs or joints (78 percent), back pain (nearly 75 percent) and memory problems (72 percent). The patients also reported ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Renal Cell Carcinoma, Lung Cancer, Colorectal Cancer, Breast Cancer, Metastatic, Non-Small Cell Lung Cancer, Basal Cell Carcinoma, Brain Tumor, Pancreatic Cancer, Skin Cancer, Ovarian Cancer, Melanoma, Breast Cancer - Adjuvant, Osteosarcoma, Endometrial Cancer, Bladder Cancer, Cervical Cancer, Melanoma - Metastatic

Many Docs Deliver Cancer Diagnosis Badly: Study

Posted 7 Jul 2010 by Drugs.com

WEDNESDAY, July 7 – One patient found out he had cancer by reading his radiology report. Another got the news when her neurologist called to say he had arranged for her to see a neurosurgeon. When she asked why, the doctor told her she had a brain tumor and hung up. A third learned she had breast cancer listening to her answering machine with her grandson sitting on her lap. A new study about how people learn of cancer diagnoses finds that many doctors have poor communication skills and often leave patients stranded with devastating information about a deadly illness, sometimes in a public setting. One-third of the cancer patients in the U.S. National Cancer Institute study recalled being told on the phone, in an emergency room, radiology department or other public hospital setting that they had cancer, most often leukemia, lymphoma or brain tumors. "It's really dismaying to think that ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Renal Cell Carcinoma, Lung Cancer, Colorectal Cancer, Breast Cancer, Metastatic, Non-Small Cell Lung Cancer, Basal Cell Carcinoma, Brain Tumor, Pancreatic Cancer, Ovarian Cancer, Skin Cancer, Melanoma, Osteosarcoma, Breast Cancer - Adjuvant, Endometrial Cancer, Bladder Cancer, Cervical Cancer, Small Cell Lung Cancer

Cost-Conscious Cancer Survivors Skip Care

Posted 14 Jun 2010 by Drugs.com

MONDAY, June 14 – Millions of Americans with a history of cancer, particularly people under age 65, are delaying or skimping on medical care because of worries about the cost of treatment, a new study suggests. The finding raises troubling questions about the long-term survival and quality of life of the 12 million adults in the United States whose lives have been forever changed by a diagnosis of cancer. "I think it's concerning because we recognize that cancer survivors have many medical needs that persist for years after their diagnosis and treatment," said study lead author Kathryn E. Weaver, an assistant professor in the Department of Social Sciences & Health Policy at Wake Forest University Baptist Medical Center in Winston-Salem, N.C. The report was published online June 14 in Cancer, a journal of the American Cancer Society. Cost concerns have posed a threat to cancer ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Renal Cell Carcinoma, Lung Cancer, Colorectal Cancer, Breast Cancer, Metastatic, Basal Cell Carcinoma, Non-Small Cell Lung Cancer, Brain Tumor, Pancreatic Cancer, Skin Cancer, Ovarian Cancer, Melanoma, Breast Cancer - Adjuvant, Osteosarcoma, Endometrial Cancer, Bladder Cancer, Cervical Cancer, Melanoma - Metastatic

Kidney Removal May Be Ill-Advised for Some Elderly

Posted 10 May 2010 by Drugs.com

MONDAY, May 10 – Removing a kidney does not seem to extend the life of elderly people with kidney cancer that has not spread, a new study finds. Instead, it suggests, people with such cancer should undergo more conservative treatments that preserve the non-cancerous parts of their kidneys. Kidney cancer cases have increased over the past 10 years, especially among older people, and doctors are trying to figure out the best way to treat what they call localized cancer in this age group. In the new study, Dr. Steve Campbell of the Cleveland Clinic and his colleagues examined the medical records of 537 people who were at least 75 years old and had localized kidney tumors. About 20 percent of them were simply observed, 53 percent had surgery that spared their kidney and 27 percent had their kidney removed. In the next four years, 28 percent of the overall group died, but just 4 percent of ... Read more

Related support groups: Renal Cell Carcinoma

Study Disputes Link Between Milk and Kidney Cancer

Posted 6 May 2010 by Drugs.com

THURSDAY, May 6 – If you were worried about drinking milk because of a reported link with a type of kidney cancer, you can relax. A new study suggests no such association exists. "The data in this study provide no concrete evidence of a need to alter milk drinking in any way," the study's lead author, Nicholas Timpson, a lecturer in genetic epidemiology at the University of Bristol in England, said in a news release from the American Association for Cancer Research. "If anything, the failure of genetic findings to replicate the association between milk and renal cell cancer suggests that fears that milk consumption might elevate cancer risk are likely to be unfounded." Timpson and his colleagues studied patients at hospitals in four European countries from 1999 to 2003, looking to see whether a genetic variation associated with lactose tolerance could be a marker for a link between ... Read more

Related support groups: Renal Cell Carcinoma

Pain Relief Often Delayed for Cancer Patients

Posted 16 Mar 2010 by Drugs.com

TUESDAY, March 16 – Palliative care services, which help people who are seriously ill relieve symptoms such as pain, are now found at most U.S. cancer centers, but many programs don't interact with patients until it's too late, study findings show. Dr. David Hui, of the University of Texas M.D. Anderson Cancer Center in Houston, and his colleagues surveyed 71 U.S. National Cancer Institute-designated cancer centers and randomly surveyed 71 other cancer centers. They received responses from 71 percent of 142 executives and 82 percent of 120 program leaders. The researchers also found that the NCI cancer centers were more likely to have palliative care programs and physicians. A report on the survey was published in the March 17 issue of the Journal of the American Medical Association. "Palliative care outpatient clinics, inpatient consultation teams, palliative care units and hospices ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Renal Cell Carcinoma, Lung Cancer, Colorectal Cancer, Breast Cancer, Metastatic, Non-Small Cell Lung Cancer, Basal Cell Carcinoma, Brain Tumor, Pancreatic Cancer, Ovarian Cancer, Skin Cancer, Melanoma, Osteosarcoma, Breast Cancer - Adjuvant, Endometrial Cancer, Bladder Cancer, Cervical Cancer, Melanoma - Metastatic

Sunlight May Help Protect Men From Kidney Cancer

Posted 8 Mar 2010 by Drugs.com

MONDAY, March 8 – Men with jobs that expose them to high levels of sunlight are less likely to develop kidney cancer than those with little or no sunlight exposure at work, says a new study. Previous research suggests that vitamin D, which is obtained from sun exposure and certain foods and supplements, may help prevent some cancers. Vitamin D is metabolized and most active within the kidneys. This new study included 1,097 male and female kidney cancer patients and 1,476 healthy people in Europe who were interviewed about their work history and other demographic information. Men with the highest levels of work-related exposure to sunlight were 24 percent to 38 percent less likely to have kidney cancer than other men. This association between job-related sunlight exposure and kidney cancer risk was not seen in women. The study is published online March 8 in the journal Cancer. The ... Read more

Related support groups: Renal Cell Carcinoma

New Drug Slows Advanced Kidney Cancer

Posted 26 Jan 2010 by Drugs.com

TUESDAY, Jan. 26 – Treating advanced kidney cancer patients with the drug pazopanib (Votrient) slowed their disease progression by 54 percent, a new study has found. The phase 3 study included 233 patients with previously untreated kidney cancer (also known as renal cell carcinoma) that was locally advanced or had spread, and 202 patients with renal cell carcinoma who had previously been treated with cytokine therapy (interferon or interleukin). The patients were randomly assigned to take pazopanib tablets (290 patients) or a placebo drug (145 patients). In the pazopanib group, it took an average 9.2 months for the cancer to progress, vs. an average 4.2 months in the placebo group. The difference was greatest in previously untreated patients (11.1 months for the pazopanib group and 2.8 months for the placebo group), but also was found among patients previously treated with cytokines ... Read more

Related support groups: Renal Cell Carcinoma

Kids Who Beat Cancer Still Face Heart Risks

Posted 9 Dec 2009 by Drugs.com

WEDNESDAY, Dec. 9 – Survivors of childhood cancer have a significantly increased risk for developing heart disease as young adults, a new study finds. The finding came from an analysis of data on 14,358 five-year cancer survivors who were diagnosed before age 21 and 3,899 siblings of cancer survivors. The cancers were leukemia, brain cancer, Hodgkin's lymphoma, non-Hodgkin's lymphoma, kidney cancer, neuroblastoma, soft tissue carcinoma or bone cancer. The study found that young adult survivors of these childhood cancers are much more likely than others in their age group to have cardiovascular problems, including heart failure, heart attack, heart inflammation and heart valve abnormalities, for up to 30 years after being treated for cancer. They also found that the risk was associated with lower exposure to chemotherapy and radiation treatment than previously thought. "Young adults who ... Read more

Related support groups: Hairy Cell Leukemia, Chronic Myelogenous Leukemia (CML), Leukemia, Renal Cell Carcinoma, Brain Tumor, Chronic Lymphocytic Leukemia (CLL), Osteosarcoma, Acute Myeloid Leukemia, Non-Hodgkin's Lymphoma, Glioblastoma Multiforme, Acute Lymphoblastic Leukemia, Pituitary Tumor, Acute Lymphocytic Leukemia, Hodgkin's Lymphoma, Malignant Glioma, Soft Tissue Sarcoma, Acute Promyelocytic Leukemia, Anaplastic Oligodendroglioma, Infection Prophylaxis, Chronic Lymphocytic Leukemia, Acute Nonlymphocytic Leukemia

U.S. Cancer Cases, Deaths Continue to Drop

Posted 8 Dec 2009 by Drugs.com

MONDAY, Dec. 7 – Better screening, healthier living and new treatments have all continued to help cut the annual number of cancer cases and deaths in the United States, a new report says. The findings showed that new cancer cases and deaths from cancer have declined significantly for both men and women and for most racial/ethnic populations. These decreases were largely due to decreased incidence and death from lung, prostate and colon cancer among men and a drop in two of the three leading cancers in women (breast and colon cancers). New diagnoses for all types of cancer in the United States declined almost 1 percent per year from 1999 to 2006 and cancer deaths dropped 1.6 percent per year from 2001 to 2006. The report, which appears in the Dec. 7 online edition of Cancer, was compiled from data by the American Cancer Society, the U.S. Centers for Disease Control and Prevention, the ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Renal Cell Carcinoma, Lung Cancer, Colorectal Cancer, Breast Cancer, Metastatic, Non-Small Cell Lung Cancer, Basal Cell Carcinoma, Brain Tumor, Pancreatic Cancer, Ovarian Cancer, Skin Cancer, Melanoma, Osteosarcoma, Breast Cancer - Adjuvant, Endometrial Cancer, Bladder Cancer, Cervical Cancer, Melanoma - Metastatic

FDA Approves GlaxoSmithKline’s Votrient for Advanced Renal Cell Cancer

Posted 2 Dec 2009 by Drugs.com

PHILADELPHIA, October 20, 2009 - GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has approved Votrient (pazopanib) to treat patients with advanced renal cell carcinoma (RCC), a form of kidney cancer. Approximately 57,700 people in the U.S. will be diagnosed with kidney cancer this year, and 13,000 people will die from this disease. "RCC is the most common malignancy of the kidney and is highly resistant to chemotherapy," said Paolo Paoletti, MD, Senior Vice President, GlaxoSmithKline Oncology R&D Unit. "While treatment has improved in the past few years with the introduction of targeted therapies, advanced RCC remains a challenging disease. Votrient will join existing targeted therapies toprovide physicians with a new oral treatment option to their patients with advanced renal cell cancer." Votrient, a once-daily, oral medication, is an angiogenesis ... Read more

Related support groups: Renal Cell Carcinoma

Page 1 2 3 Next

Ask a Question

Further Information

Related Condition Support Groups

Wilms' Tumor, Cancer

Related Drug Support Groups

Provera, Depo-Provera, medroxyprogesterone, Votrient, Tarceva, Avastin, Xeloda, Sutent, Afinitor, view more... Nexavar, PegIntron, pazopanib, capecitabine, sunitinib, sorafenib, Inlyta, erlotinib, bevacizumab, everolimus, Torisel, interferon alfa-2a, peginterferon alfa-2b, Depo-Provera Contraceptive, Proleukin, aldesleukin, Roferon-A, depo-subQ provera 104, axitinib, Amen, Cycrin, temsirolimus, Curretab